Merck to Use HTG s Array Plate Assay Technology | GenomeWeb

NEW YORK, May 4 (GenomeWeb News) - HTG today said that Merck has licensed its ArrayPlate qNPA (quantitative nuclease protection assay) technology for its drug discovery research.

ArrayPlate qNPA offers multiplexed measurement of 16 mRNA species in each well of a standard 96-well microplate, HTG said.

HTG did not provide financial details of the licensing agreement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.